232 related articles for article (PubMed ID: 10744365)
1. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
[TBL] [Abstract][Full Text] [Related]
2. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
4. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Akins RL; Rybak MJ
Antimicrob Agents Chemother; 2000 Jul; 44(7):1925-9. PubMed ID: 10858356
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of arbekacin against clinical isolates of Staphylococcus species and gram-negative bacilli].
Lee J; Kim CK; Roh KH; Lee H; Yum JH; Yong D; Lee K; Chong Y
Korean J Lab Med; 2007 Aug; 27(4):292-7. PubMed ID: 18094591
[TBL] [Abstract][Full Text] [Related]
8. Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Lee DG; Chun HS; Yim DS; Choi SM; Choi JH; Yoo JH; Shin WS; Kang MW
Antimicrob Agents Chemother; 2003 Dec; 47(12):3768-73. PubMed ID: 14638480
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
Watanabe T; Ohashi K; Matsui K; Kubota T
J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
[TBL] [Abstract][Full Text] [Related]
10. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan.
Ida T; Okamoto R; Shimauchi C; Okubo T; Kuga A; Inoue M
J Clin Microbiol; 2001 Sep; 39(9):3115-21. PubMed ID: 11526138
[TBL] [Abstract][Full Text] [Related]
11. Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
Lee JY; Oh WS; Ko KS; Heo ST; Moon CS; Ki HK; Kiem S; Peck KR; Song JH
J Korean Med Sci; 2006 Apr; 21(2):188-92. PubMed ID: 16614499
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance.
Ishino K; Ishikawa J; Ikeda Y; Hotta K
J Antibiot (Tokyo); 2004 Oct; 57(10):679-86. PubMed ID: 15638329
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Kono K; Takeda S; Tatara I; Arakawa K
Jpn J Antibiot; 1994 Jun; 47(6):710-9. PubMed ID: 8072179
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
[TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals.
Cordeiro JC; Reis AO; Miranda EA; Sader HS;
Braz J Infect Dis; 2001 Jun; 5(3):130-5. PubMed ID: 11506776
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
18. Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Kobayashi T; Gomi K; Abe T; Nukiwa T; Watanabe A
FEMS Microbiol Lett; 2000 Sep; 190(2):299-303. PubMed ID: 11034295
[TBL] [Abstract][Full Text] [Related]
19. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Kobayashi Y
Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
[TBL] [Abstract][Full Text] [Related]
20. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A
Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
